Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study ; volume:21 ; number:1 ; day:22 ; month:3 ; year:2023 ; pages:1-7 ; date:12.2023
Pediatric rheumatology ; 21, Heft 1 (22.3.2023), 1-7, 12.2023
- Creator
-
Levälampi, Tiina
Kärki, Johanna
Rebane, Katariina
Vähäsalo, Paula
Malin, Merja
Kröger, Liisa
Grönlund, Minna-Maija
Backström, Maria
Pohjankoski, Heini
Kautiainen, Hannu
Jokiranta, Sakari
Aalto, Kristiina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-023-00801-2
- URN
-
urn:nbn:de:101:1-2023081110420365749137
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Levälampi, Tiina
- Kärki, Johanna
- Rebane, Katariina
- Vähäsalo, Paula
- Malin, Merja
- Kröger, Liisa
- Grönlund, Minna-Maija
- Backström, Maria
- Pohjankoski, Heini
- Kautiainen, Hannu
- Jokiranta, Sakari
- Aalto, Kristiina
- SpringerLink (Online service)
Other Objects (12)
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Predictors of response to methotrexate in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay